HER2 Support Group Forums - View Single Post - Celldex announces final results from CDX-011 Phase 2b study on GPNMB-expressing breas

News · 12-09-2012, 09:30 PM

Celldex Therapeutics, Inc. today announced final results from the Company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer.

More...

12-09-2012, 09:30 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,135	Celldex announces final results from CDX-011 Phase 2b study on GPNMB-expressing breas Celldex Therapeutics, Inc. today announced final results from the Company's randomized Phase 2b EMERGE study of CDX-011 in patients with glycoprotein NMB (GPNMB)-expressing, advanced, heavily pretreated breast cancer. More...